人脐带间充质干细胞通过调控OPG/RANKL比值对骨质疏松大鼠的影响及机制研究

卫莹; 刘师伟; 段瑞雪; 赵宇翔; 李楠; 吴亚茹

doi:10.13406/j.cnki.cyxb.002972

您当前的位置：

首页 >

文章列表页 >

人脐带间充质干细胞通过调控OPG/RANKL比值对骨质疏松大鼠的影响及机制研究

骨科学 | 更新时间：2022-06-24

- 人脐带间充质干细胞通过调控OPG/RANKL比值对骨质疏松大鼠的影响及机制研究
- Effects and mechanism of human umbilical cord mesenchymal stem cells on osteoporosis rats by regulating the ratio of osteoprotegerin/receptor activator of nuclear factor-κB ligand
- 重庆医科大学学报 2022年47卷第5期页码：503-510
- 作者机构：
  
  1.山西医科大学基础医学院生物化学与分子生物学教研室，太原　030001
  2.山西白求恩医院内分泌科，太原　030032
  3.太原市中心医院内分泌科，太原　030009
- 作者简介：
  
  卫莹，Email：15234707831@163.com，研究方向：内分泌代谢病基础与临床研究。
  刘师伟，Email：lswspring6@aliyun.com。
- 基金信息：
  
  中国糖尿病英才研究资助项目(2019-N-01-28);山西省重点研发计划资助项目(201803D31133);山西省回国留学人员科研资助项目(2020-180);山西省留学人员科技活动择优资助项目(20200032)
- DOI：10.13406/j.cnki.cyxb.002972
  中图分类号： R580
- 纸质出版日期：2022-05-28，
  
  收稿日期：2021-05-15，
扫描看全文
卫莹, 刘师伟, 段瑞雪, 等. 人脐带间充质干细胞通过调控OPG/RANKL比值对骨质疏松大鼠的影响及机制研究[J]. 重庆医科大学学报, 2022,47(5):503-510.

Ying Wei, Shiwei Liu, Ruixue Duan, et al. Effects and mechanism of human umbilical cord mesenchymal stem cells on osteoporosis rats by regulating the ratio of osteoprotegerin/receptor activator of nuclear factor-κB ligand[J]. Journal of Shanxi Agricultural Sciences, 2022,47(5):503-510.
卫莹, 刘师伟, 段瑞雪, 等. 人脐带间充质干细胞通过调控OPG/RANKL比值对骨质疏松大鼠的影响及机制研究[J]. 重庆医科大学学报, 2022,47(5):503-510. DOI： 10.13406/j.cnki.cyxb.002972.

Ying Wei, Shiwei Liu, Ruixue Duan, et al. Effects and mechanism of human umbilical cord mesenchymal stem cells on osteoporosis rats by regulating the ratio of osteoprotegerin/receptor activator of nuclear factor-κB ligand[J]. Journal of Shanxi Agricultural Sciences, 2022,47(5):503-510. DOI： 10.13406/j.cnki.cyxb.002972.

摘要

目的：

探讨人脐带间充质干细胞（human umbilical cord mesenchymal stem cells，HUC-MSCs）对骨质疏松大鼠的影响及机制。

方法：

将30只SPF级6月龄雌性SD大鼠随机分为3组：假手术组（Sham组）、卵巢切除组（OVX组）、卵巢切除+HUC-MSCs干预组（4×10

/3 d，HUC-MSCs干预组），每组各10只，Sham组切除大鼠腹腔少量脂肪，其余各组均去除双侧卵巢建立骨质疏松大鼠模型。建模成功后，HUC-MSCs组用干细胞干预12周，其余2组用等剂量生理盐水干预。干预结束后，通过骨代谢血清指标血钙（calcium，Ca）、血磷（phosphorus，P）、碱性磷酸酶（alkaline phosphatase，ALP）、Ⅰ型胶原C端肽（c-terminal peptide of typeⅠcollagen，CTX）、骨组织形态计量学参数测量、骨密度检测、成骨细胞表面积/骨表面积比（osteoblast surface/bone surface，ObS/BS）和破骨细胞表面积/骨表面积比（osteoclast surface area/bone surface，OcS/BS），评估大鼠骨质疏松改善情况，同时通过Western blot探究各组大鼠骨保护素（osteoprotegerin，OPG）/核因子-κB受体活化因子配体（receptor activator of nuclear factor-κB ligand，RANKL）、β-连环蛋白（β-catenin）、Runt相关转录因子2（Runt-related transcription factor 2，Runx2）的表达情况。

结果：

HUC-MSCs组大鼠血清Ca、ALP含量明显高于OVX组（2.320±0.188 vs.1.822±0.139；79.584±8.349 vs.43.644±5.369；均

=0.000），P、CTX含量明显低于OVX组（1.651±0.068 vs.1.864±0.076，

=0.000；119.832±18.180 vs.144.272±15.629，

=0.039）；HUC-MSCs组骨小梁结构得到明显改善，骨密度、骨小梁数目、骨小梁面积比、ObS/BS均明显高于OVX组（161.114±16.726 vs.126.558±7.100，

=0.009；1.702±0.220 vs.1.051±0.323，

=0.020；33.111±6.101 vs.19.575±5.629，

=0.022；45.279±3.947 vs.33.948±7.339，

=0.041），骨小梁分离度、OcS/BS明显低于OVX组（0.592±0.066 vs.0.845±0.165，

=0.018；37.532±3.910 vs.44.891±3.615，

=0.026）；Western blot结果显示HUC-MSCs组OPG/RANKL比值、β-catenin、Runx2的蛋白表达量明显高于OVX组（0.776±0.045 vs.0.097±0.063，

=0.000；0.590±0.057 vs.0.202±0.088，

=0.000；0.595±0.078 vs.0.239±0.071，

=0.001）。

结论：

HUC-MSCs可以通过Wnt/β-catenin/Runx2通路调节OPG/RANKL比值，促进骨形成，抑制骨吸收，改善骨质疏松。

Abstract

Objective

To investigate the effect of human umbilical cord mesenchymal stem cells (HUC-MSCs) on osteoporosis rats and its mechanism.

Methods

Thirty SPF grade 6-month-old female rats were randomly divided into three groups: sham operation group (Sham group)

ovariectomy group (OVX group) and HUC-MSCs intervention group (HUC-MSCs group) (4×10

/3 day)

with 10 rats in each group. In Sham group

a small amount of abdominal fat was removed

and the other groups were removed bilateral ovaries to establish osteoporosis rat model. After successful modeling

HUC-MSCs group was intervened with stem cells for 12 w

while the other two groups were intervened with equal dose of normal saline. After the intervention

calcium (Ca)

phosphorus (P)

alkaline phosphatase (ALP)

c-terminal peptide of type I collagen (CTX)

histomorphometric parameters of femur

bone mineral density (BMD)

osteoblast surface/bone surface ratio (ObS/BS) and osteoclast surface area/bone surface (OcS/BS) were used to evaluate the improvement of osteoporosis in rats. Meanwhile

the expression of osteoprotegerin (OPG)

receptor activator of nuclear factor-κB ligand (RANKL)

β-catenin and Runt-related transcription factor 2 (Runx2) were detected by Western blot.

Results

The contents of serum Ca and ALP in HUC-MSCs group were significantly higher than those in OVX group (2.320±0.188 vs.1.822±0.139; 79.584±8.349 vs.43.644±5.369; all

=0.000) ; P and CTX contents were significantly lower than those in OVX group (1.651±0.068 vs.1.864±0.076

=0.000; 119.832±18.180 vs.144.272±15.629

=0.039) ; BMD

the number of trabecular bone

the ratio of trabecular area and ObS/BS in HUC-MSCs group were significantly higher than those in OVX group (161.114±16.726 vs.126.558±7.100

=0.009; 1.702±0.220 vs.1.051±0.323

=0.020; 33.111±6.101 vs.19.575±5.629

=0.022; 45.279±3.947 vs.33.948±7.339

=0.041) ; the bone trabecular separation and OcS/BS in HUC-MSCs group were significantly lower than those in OVX group (0.592±0.066 vs.0.845±0.165

=0.018; 37.532±3.910 vs.44.891±3.615

=0.026) ; the results of Western blot showed that the ratio of OPG/RANKL and the protein expression of β-catenin and Runx2 in HUC-MSCs group were significantly higher than those in OVX group (0.776±0.045 vs.0.097±0.063

=0.000; 0.590±0.057 vs.0.202±0.088

=0.000; 0.595±0.078 vs.0.239±0.071

=0.001) .

Conclusion

HUC-MSCs can regulate OPG/RANKL ratio through Wnt/β-catenin/Runx2 pathway

thus promoting bone formation

inhibiting bone resorption and improving osteoporosis.

关键词

骨质疏松人脐带间充质干细胞骨代谢骨保护素/核因子-κB受体活化因子配体

Keywords

osteoporosishuman umbilical cord mesenchymal stem cellbone metabolismosteoprotegerin/receptor activator of nuclear factor-κB ligand

references

Leslie WD, Morin SN. Osteoporosis epidemiology 2013: implications for diagnosis, risk assessment, and treatment[J]. Curr Opin Rheumatol, 2014, 26(4): 440-446.

Chen P, Li ZZ, Hu YH. Prevalence of osteoporosis in China: a meta-analysis and systematic review[J]. BMC Public Health, 2016, 16(1): 1039.

Beekman KM, Veldhuis-Vlug AG, den Heijer M, et al. The effect of raloxifene on bone marrow adipose tissue and bone turnover in postmenopausal women with osteoporosis[J]. Bone, 2019, 118: 62-68.

刘秋英, 利奕成, 何绍清, 等. 脐带间充质干细胞治疗大鼠骨质疏松的初步研究[J]. 中国细胞生物学学报, 2013, 35(11): 1592-1597.

Liu QY, Li YC, He SQ, et al. Effect of umbilical cord mesenchymal stem cell transplanting on retinoicacid-induced osteoporosis in rats[J]. Chin J Cell Biol, 2013, 35(11): 1592-1597.

Al-Nbaheen M, Vishnubalaji R, Ali DL, et al. Human stromal (mesenchymal) stem cells from bone marrow, adipose tissue and skin exhibit differences in molecular phenotype and differentiation potential[J]. Stem Cell Rev Rep, 2013, 9(1): 32-43.

Santos JM, Bárcia RN, Simões SI, et al. The role of human umbilical cord tissue-derived mesenchymal stromal cells (UCX®) in the treatment of inflammatory arthritis[J]. J Transl Med, 2013, 11: 18.

姚映灵, 何玲, 毕杨, 等. 人滑膜间充质干细胞与人脐带间充质干细胞的生物学性状比较[J]. 中国细胞生物学学报, 2021, 43(2): 302-310.

Yao YL, He L, Bi Y, et al. Comparison of biological characteristics of human synovial mesenchymal stem cells and human umbilical cord mesenchymal stem cells[J]. Chin J Cell Biol, 2021, 43(2): 302-310.

Rodríguez JP, Garat S, Gajardo H, et al. Abnormal osteogenesis in osteoporotic patients is reflected by altered mesenchymal stem cells dynamics[J]. J Cell Biochem, 1999, 75(3): 414-423.

黄健萍, 林思恩, 吴玲芝, 等. 复方脑复康预防大鼠去卵巢后骨质疏松的研究[J]. 重庆医科大学学报, 2011, 36(11): 1292-1295.

Huang JP, Lin SE, Wu LZ, et al. Effects of compound piracetam in preventing osteoporosis in ovariectomized rats[J]. J Chongqing Med Univ, 2011, 36(11): 1292-1295.

Liang M, Liu WG, Peng ZB, et al. The therapeutic effect of secretome from human umbilical cord-derived mesenchymal stem cells in age-related osteoporosis[J]. Artif Cells Nanomed Biotechnol, 2019, 47(1): 1357-1366.

Ezquerra S, Zuleta A, Arancibia R, et al. Functional properties of human-derived mesenchymal stem cell spheroids: a meta-analysis and systematic review[J]. Stem Cells Int, 2021, 2021: 8825332.

Ekram S, Khalid S, Bashir I, et al. Human umbilical cord-derived mesenchymal stem cells and their chondroprogenitor derivatives reduced pain and inflammation signaling and promote regeneration in a rat intervertebral disc degeneration model[J]. Mol Cell Biochem, 2021, 476(8): 3191-3205.

Semenova E, Grudniak MP, Machaj EK, et al. Mesenchymal stromal cells from different parts of umbilical cord: approach to comparison& characteristics[J]. Stem Cell Rev Rep, 2021, 17(5): 1780-1795.

Bertoni L, Jacquet-Guibon S, Branly T, et al. Evaluation of allogeneic bone-marrow-derived and umbilical cord blood-derived mesenchymal stem cells to prevent the development of osteoarthritis in an equine model[J]. Int J Mol Sci, 2021, 22(5): 2499.

Tang L, Gao XH, Yang XY, et al. Ladder-climbing training prevents bone loss and microarchitecture deterioration in diet-induced obese rats[J]. Calcif Tissue Int, 2016, 98(1): 85-93.

An JH, Park H, Song JA, et al. Transplantation of human umbilical cord blood-derived mesenchymal stem cells or their conditioned medium prevents bone loss in ovariectomized nude mice[J]. Tissue Eng Part A, 2013, 19(5/6): 685-696.

Vasikaran S, Eastell R, Bruyère O, et al. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards[J]. Osteoporos Int, 2011, 22(2): 391-420.

Williams C, Sapra A. Osteoporosis markers[M]//StatPearls[Internet]. Treasure Island (FL): StatPearls Publising, 2021.

Hong B, Lee S, Shin N, et al. Bone regeneration with umbilical cord blood mesenchymal stem cells in femoral defects of ovariectomized rats[J]. Osteoporos Sarcopenia, 2018, 4(3): 95-101.

Fu YS, Lu CH, Chu KA, et al. Xenograft of human umbilical mesenchymal stem cells from wharton's jelly differentiating into osteocytes and reducing osteoclast activity reverses osteoporosis in ovariectomized rats[J]. Cell Transplant, 2018, 27(1): 194-208.

李苏华, 李惠, 廖湘平, 等. NGAL、OPG、RANKL及DAS28对RA骨质疏松的预测作用[J]. 重庆医科大学学报, 2019, 44(9): 1155-1158.

Li SH, Li H, Liao XP, et al. Value of neutrophil gelatinase-associated lipocalin, osteoprotegerin, receptor activator of nuclear factor-kappa B ligand, and 28-joint disease activity score in predicting osteoporosis in patients with rheumatoid arthritis[J]. J Chongqing Med Univ, 2019, 44(9): 1155-1158.

Mountzios G, Dimopoulos MA, Bamias A, et al. Abnormal bone remodeling process is due to an imbalance in the receptor activator of nuclear factor-κB ligand (RANKL)/osteoprotegerin (OPG) axis in patients with solid tumors metastatic to the skeleton[J]. Acta Oncol, 2007, 46(2): 221-229.

Yang G, Kim YN, Kim H, et al. Effect of human umbilical cord matrix-derived mesenchymal stem cells on bisphosphonate-related osteonecrosis of the jaw[J]. Tissue Eng Regen Med, 2021, 18(6): 975-988.

Yang N, Liu DK, Zhang X, et al. Effects of ginsenosides on bone remodelling for novel drug applications: a review[J]. Chin Med, 2020, 15: 42.

Han NN, Zheng Y, Li R, et al. β-catenin enhances odontoblastic differentiation of dental pulp cells through activation of Runx2[J]. PLoS One, 2014, 9(2): e88890.

Yin YK, Ding LX, Hou Y, et al. Upregulating microRNA-410 or downregulating Wnt-11 increases osteoblasts and reduces osteoclasts to alleviate osteonecrosis of the femoral head[J]. Nanoscale Res Lett, 2019, 14(1): 383.

Liu GZ, Vijayakumar S, Grumolato L, et al. Canonical Wnts function as potent regulators of osteogenesis by human mesenchymal stem cells[J]. J Cell Biol, 2009, 185(1): 67-75.

Bae YK, Kwon JH, Kim M, et al. Intracellular calcium determines the adipogenic differentiation potential of human umbilical cord blood-derived mesenchymal stem cells via the Wnt5a/β-catenin signaling pathway[J]. Stem Cells Int, 2018, 2018: 6545071.

查看原文

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

人参皂苷 Rg₃对骨质疏松大鼠骨代谢及肠钙吸收功能的影响

绝经期女性骨密度调查及相关因素分析

护骨胶囊对绝经后妇女骨量及骨代谢的作用

辛伐他汀对去势大鼠骨质疏松防治作用的试验研究